Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Intestinal2466 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A43504 | 31570275 | J Hepatol | Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease. | 2019 | Details |
| A43525 | 31520590 | Gastrointest Endosc | Endoscopic abdominal exploration in the acute abdomen: No longer a contraindication? | 2019 | Details |
| A43536 | 31480433 | Int J Mol Sci | Bone Diseases in Patients with Chronic Liver Disease. | 2019 | Details |
| A43568 | 31388093 | Nat Rev Immunol | The intestinal microbiota fuelling metabolic inflammation. | 2019 | Details |
| A43587 | 31345023 | J Agric Food Chem | Processed Meat Protein Promoted Inflammation and Hepatic Lipogenesis by Upregulating Nrf2/Keap1 Signaling Pathway in Glrx-Deficient Mice. | 2019 | Details |
| A43610 | 31296380 | Biochem Biophys Res Commun | Spinal miR-34a regulates inflammatory pain by targeting SIRT1 in complete Freund's adjuvant mice. | 2019 | Details |
| A43611 | 31294797 | J Burn Care Res | The Influence of Obesity on Treatment and Outcome of Severely Burned Patients. | 2019 | Details |
| A43620 | 31273795 | Hepatology | Fructose Promotion of Intestinal and Liver Injury: A Sugar by Any Other Name That Isn't So Sweet. | 2019 | Details |
| A43676 | 31132831 | Korean J Gastroenterol | [Hepatobiliary Manifestation of Inflammatory Bowel Disease]. | 2019 | Details |
| A43705 | 31076986 | Dig Dis Sci | Serum and Fecal Oxylipins in Patients with Alcohol-Related Liver Disease. | 2019 | Details |
| A43716 | 31048404 | J Lipid Res | Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorption. | 2019 | Details |
| A43726 | 31018107 | Annu Rev Nutr | Bile Acids as Metabolic Regulators and Nutrient Sensors. | 2019 | Details |
| A43783 | 30890204 | Gene Expr | Sterol 12α-Hydroxylase Aggravates Dyslipidemia by Activating the Ceramide/mTORC1/SREBP-1C Pathway via FGF21 and FGF15. | 2019 | Details |
| A43792 | 30873652 | J Intern Med | Indoles: metabolites produced by intestinal bacteria capable of controlling liver disease manifestation. | 2019 | Details |
| A43829 | 30767680 | Am J Physiol Gastrointest Liver Physiol | Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful either. | 2019 | Details |
| A43838 | 30741841 | J Clin Gastroenterol | Thirty Years of Lactobacillus rhamnosus GG: A Review. | 2019 | Details |
| A43843 | 30721959 | Adv Nutr | Mechanisms of Action of Probiotics. | 2019 | Details |
| A43873 | 30629464 | FASEB J | Maternal prebiotic supplementation reduces fatty liver development in offspring through altered microbial and metabolomic profiles in rats. | 2019 | Details |
| A43889 | 30559444 | Nat Rev Gastroenterol Hepatol | A spotlight on pathogenesis, interactions and novel therapeutic options in NAFLD. | 2019 | Details |
| A43891 | 30553904 | JACC Heart Fail | Heart Failure and Liver Disease: Cardiohepatic Interactions. | 2018 | Details |
| A43895 | 30522511 | Lipids Health Dis | Cordycepin reduces weight through regulating gut microbiota in high-fat diet-induced obese rats. | 2018 | Details |
| A43896 | 30541093 | Am J Clin Nutr | A 12-wk whole-grain wheat intervention protects against hepatic fat: the Graandioos study, a randomized trial in overweight subjects. | 2018 | Details |
| A43904 | 30498606 | Case Rep Gastrointest Med | Gastrointestinal Bleeding Secondary to Portal Hypertensive Duodenopathy in a Patient with Decompensated Liver Cirrhosis. | 2018 | Details |
| A43919 | 30464044 | Gut | Gut microbiota dynamics and uraemic toxins: one size does not fit all. | 2018 | Details |
| A43926 | 30444134 | Biomark Med | How our understanding of the microbiome has changed the way we look at liver diseases. | 2018 | Details |
| A43933 | 30423189 | Pediatr Ann | Hepatobiliary Manifestations in Systemic Disease. | 2018 | Details |
| A43938 | 30408104 | PLoS One | Effects of fructose-containing sweeteners on fructose intestinal, hepatic, and oral bioavailability in dual-catheterized rats. | 2018 | Details |
| A43944 | 30385796 | Sci Rep | Effect of coffee or coffee components on gut microbiome and short-chain fatty acids in a mouse model of metabolic syndrome. | 2018 | Details |
| A43945 | 30379616 | Annu Rev Physiol | Phospholipid Remodeling in Physiology and Disease. | 2018 | Details |
| A43951 | 30367438 | MMW Fortschr Med | [Gut-liver axis: How intestinal bacteria affect the liver]. | 2018 | Details |
| A43973 | 30265576 | FASEB J | Monoacylglycerol lipase deficiency affects diet-induced obesity, fat absorption, and feeding behavior in CB1 cannabinoid receptor-deficient mice. | 2018 | Details |
| A43988 | 30215868 | Hepatology | Inflammation and Microbiota Fingerprint: Delphi's Oracle for Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma? | 2018 | Details |
| A43990 | 30210263 | Mediators Inflamm | Response to: Comment on "Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease". | 2018 | Details |
| A43998 | 30185915 | Nat Rev Gastroenterol Hepatol | Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis. | 2018 | Details |
| A44005 | 30158571 | Nat Rev Gastroenterol Hepatol | Gut microbiome, microbial metabolites and the development of NAFLD. | 2018 | Details |
| A44017 | 30147133 | Hosp Pharm | New Medications in the Treatment of Nonalcoholic Steatohepatitis. | 2018 | Details |
| A44026 | 30116145 | Mediators Inflamm | Comment on "Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease". | 2018 | Details |
| A44065 | 29993258 | Crit Rev Food Sci Nutr | The target cells of anthocyanins in metabolic syndrome. | 2018 | Details |
| A44078 | 29936174 | Metabolism | Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis. | 2018 | Details |
| A44080 | 29901549 | J Pediatr Gastroenterol Nutr | A Bibliometric Analysis of Clinical and Translational Research in Pediatric Gastroenterology From 1970 to 2017. | 2018 | Details |
| A44107 | 29743802 | J Clin Exp Hepatol | Upper Gastrointestinal Bleed Due to Invasive Hepatocellular Carcinoma and Hepato-Gastric Fistula. | 2017 | Details |
| A44118 | 29694888 | Cell Rep | Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages. | 2018 | Details |
| A44159 | 29549040 | Gastroenterology | Lamins and Lamin-Associated Proteins in Gastrointestinal Health and Disease. | 2018 | Details |
| A44176 | 29507905 | Hepatol Commun | Pyrroloquinoline quinone prevents developmental programming of microbial dysbiosis and macrophage polarization to attenuate liver fibrosis in offspring of obese mice. | 2018 | Details |
| A44225 | 29327584 | J Agric Food Chem | Gamma-aminobutyric Acid Enriched Rice Bran Diet Attenuates Insulin Resistance and Balances Energy Expenditure via Modification of Gut Microbiota and Short-Chain Fatty Acids. | 2018 | Details |
| A44288 | 29149924 | Rheum Dis Clin North Am | Gastrointestinal and Hepatic Disease in Spondyloarthritis. | 2018 | Details |
| A44325 | 29016560 | Am J Gastroenterol | Abdominal Pain in the Roux-en-Y Gastric Bypass Patient. | 2017 | Details |
| A44337 | 28936971 | Turk J Gastroenterol | Nonalcoholic steatohepatitis and gut microbiota: Future perspectives on probiotics in metabolic liver diseases. | 2017 | Details |
| A44341 | 28914862 | Ter Arkh | [Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation]. | 2017 | Details |
| A44347 | 28898219 | Nat Biotechnol | Nestlé moves into gut microbiome tests. | 2017 | Details |
| A44359 | 28847030 | Semin Liver Dis | Macrophages in Nonalcoholic Fatty Liver Disease: A Role Model of Pathogenic Immunometabolism. | 2017 | Details |
| A44369 | 28804516 | Therap Adv Gastroenterol | The role of sebelipase alfa in the treatment of lysosomal acid lipase deficiency. | 2017 | Details |
| A44372 | 28795381 | Chin J Integr Med | Research progress on prevention and treatment of glucolipid metabolic disease with integrated traditional Chinese and Western medicine. | 2017 | Details |
| A44389 | 28736228 | Biochim Biophys Acta Gen Subj | DBZ is a putative PPARγ agonist that prevents high fat diet-induced obesity, insulin resistance and gut dysbiosis. | 2017 | Details |
| A44472 | 28513633 | Nat Rev Gastroenterol Hepatol | NAFLD: A gut microbiome signature for advanced fibrosis diagnosis in NAFLD. | 2017 | Details |
| A44530 | 28333140 | Cell Death Dis | Metabolic and molecular insights into an essential role of nicotinamide phosphoribosyltransferase. | 2017 | Details |
| A44543 | 28292408 | Gastrointest Endosc Clin N Am | Hydrothermal Duodenal Mucosal Resurfacing: Role in the Treatment of Metabolic Disease. | 2017 | Details |
| A44551 | 28242319 | Clin Gastroenterol Hepatol | White Paper AGA: POWER - Practice Guide on Obesity and Weight Management, Education, and Resources. | 2017 | Details |
| A44559 | 28212759 | J Am Acad Dermatol | Psoriasis and comorbid diseases: Epidemiology. | 2017 | Details |
| A44564 | 28192107 | Gastroenterology | Gastrointestinal Complications of Obesity. | 2017 | Details |
| A44573 | 28140328 | Adv Nutr | Impact of Dietary Fibers on Nutrient Management and Detoxification Organs: Gut, Liver, and Kidneys. | 2016 | Details |
| A44584 | 28092152 | FP Essent | Issues in Nutrition: Dietary Considerations in Select Chronic Conditions. | 2017 | Details |
| A44602 | 28027591 | Hepatology | TM6SF2 rs58542926 impacts lipid processing in liver and small intestine. | 2017 | Details |
| A44628 | 27890867 | Gut Liver | Obesity-Related Digestive Diseases and Their Pathophysiology. | 2017 | Details |
| A44646 | 27822554 | mSystems | Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism. | 2016 | Details |
| A44689 | 27734248 | Dig Dis Sci | FXR Agonists: From Bench to Bedside, a Guide for Clinicians. | 2016 | Details |
| A44693 | 27718255 | Hepatology | Nonalcoholic steatohepatitis and the intestinal microbiota. | 2016 | Details |
| A44744 | 27477080 | Transl Res | Gut microbiome and liver disease. | 2016 | Details |
| A44775 | 27347902 | Compr Physiol | Functions of the Gallbladder. | 2016 | Details |
| A44799 | 27266041 | Nihon Naika Gakkai Zasshi | [Clinical Importance of Non-alcoholic Fatty Liver Diseases. Topics: IV. Relation of NAFLD with lifestyle-related disease including obesity, dyslipidemia and hypertension]. | 2016 | Details |
| A44801 | 27266039 | Nihon Naika Gakkai Zasshi | [Clinical Importance of Non-alcoholic Fatty Liver Diseases. Topics: II. Complexity in pathogenesis of nonalcoholic fatty liver disease]. | 2016 | Details |
| A44808 | 27252163 | Physiology (Bethesda) | Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance. | 2016 | Details |
| A44809 | 27243019 | Inflamm Intest Dis | Does the Intestinal Microbiota Explain Differences in the Epidemiology of Liver Disease between East and West? | 2016 | Details |
| A44818 | 27189109 | Sci Rep | Chronic administration of Angelica sinensis polysaccharide effectively improves fatty liver and glucose homeostasis in high-fat diet-fed mice. | 2016 | Details |
| A44839 | 27109980 | Transplant Proc | Adult Intestinal and Multivisceral Transplantation: Experience From a Single Center in the United Kingdom. | 2016 | Details |
| A44859 | 27048892 | Best Pract Res Clin Gastroenterol | Dysbiosis in gastrointestinal disorders. | 2016 | Details |
| A44878 | 26998910 | Hepatology | Predictive roles of gut dysbiosis on the severity of nonalcoholic fatty liver disease. | 2016 | Details |
| A44883 | 26984853 | Gut | Gut microbiota produce alcohol and contribute to NAFLD. | 2016 | Details |
| A44921 | 26786686 | Gut | Altered intestinal microbiota as a major driving force in alcoholic steatohepatitis. | 2016 | Details |
| A44954 | 26628846 | J Clin Exp Hepatol | Intestinal FXR: A New Therapeutic Target for Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A44972 | 26571774 | Nihon Naika Gakkai Zasshi | [Gut Microbiota and Internal Diseases: Update Information. Topics: III. NASH/NAFLD and gut microbiota]. | 2015 | Details |
| A44981 | 26534773 | Dig Liver Dis | The association between primary bacteremia of presumed gastrointestinal origin and nonalcoholic fatty liver disease. | 2015 | Details |
| A45008 | 26447962 | J Clin Gastroenterol | Probiotics in Pediatric Liver Disease. | 2016 | Details |
| A45045 | 26308759 | Altern Ther Health Med | Red Yeast Rice Plus Berberine: Practical Strategy for Promoting Vascular and Metabolic Health. | 2015 | Details |
| A45058 | 26239845 | Nat Rev Gastroenterol Hepatol | NASH: CX3CR1-a direct line to gut-liver crosstalk? | 2015 | Details |
| A45091 | 26103612 | Curr Opin Lipidol | Bariatric surgery, lipoprotein metabolism and cardiovascular risk. | 2015 | Details |
| A45098 | 26087059 | Clin Transl Gastroenterol | The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease. | 2015 | Details |
| A45108 | 26054998 | Surg Technol Int | Endoscopic Therapeutic Option for Weight Loss and Control of Type 2 Diabetes: the Duodenal-Jejunal Bypass Liner. | 2015 | Details |
| A45118 | 26026745 | Gastroenterology | Tail Tale: nNOSdel1203-1434 Predicts Global Defects in Esophagogastrointestinal Transit. | 2015 | Details |
| A45127 | 25998695 | Hepatology | Intestinal farnesoid X receptor puts a fresh coat of wax on fatty liver. | 2015 | Details |
| A45145 | 25922396 | Clin Infect Dis | New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. | 2015 | Details |
| A45158 | 25864227 | Ann Hepatol | Obeticholic acid: expanding the therapeutic landscape of NASH. | 2016 | Details |
| A45213 | 25645967 | Nat Rev Gastroenterol Hepatol | NAFLD. Leaky guts: intestinal permeability and NASH. | 2015 | Details |
| A45216 | 25635125 | J Lipid Res | The combination of ezetimibe and ursodiol promotes fecal sterol excretion and reveals a G5G8-independent pathway for cholesterol elimination. | 2015 | Details |
| A45217 | 28210672 | Cell Mol Gastroenterol Hepatol | The Gut Microbiota, Intestinal Permeability, Bacterial Translocation, and Nonalcoholic Fatty Liver Disease: What Comes First? | 2015 | Details |
| A45269 | 25469034 | World J Gastroenterol | Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion? | 2014 | Details |
| A45277 | 25436233 | ScientificWorldJournal | Is there a role for probiotics in liver disease? | 2014 | Details |
| A45279 | 25421586 | Nat Rev Gastroenterol Hepatol | NAFLD: obeticholic acid for the treatment of fatty liver disease--NASH no more? | 2014 | Details |
| A45311 | 25239591 | Gastroenterology | Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. | 2014 | Details |
| A45329 | 25153016 | J Chin Med Assoc | Hypertension is an important predictor of recurrent colorectal adenoma after screening colonoscopy with adenoma polypectomy. | 2014 | Details |